Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly to stop developing schizophrenia drug
Yahoo/Reuters
Wednesday, August 29, 2012 - 8:30am
tags:
Eli Lilly, schizophrenia, pomaglumetad methionil
Stribild: It's FDA-Approved, but Will It Sell?
Motley Fool
Wednesday, August 29, 2012 - 8:29am
tags:
FDA, HIV, Gilead, Stribild
5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year
Seeking Alpha
Tuesday, August 28, 2012 - 12:27pm
tags:
Sucampo, Savient, Gentium, Alexza, Horizon Pharma
Medicines Co. says cardiology group guidelines recommend Angiomax over Heparin
Yahoo/Fly on the Wall
Tuesday, August 28, 2012 - 12:26pm
tags:
Medicines Company, Angiomax, Heparin, myocardial infarction
Isis Pharmaceuticals to receive $1.4 million from Alnylam
Yahoo
Tuesday, August 28, 2012 - 12:25pm
tags:
Isis Pharmaceuticals, Alnylam
Forest adopts 'poison pill' to fend off Icahn
Fierce Pharma
Tuesday, August 28, 2012 - 11:34am
tags:
Forest Labs, poison pill, Carl Icahn
Sanofi's Genzyme recalls kidney transplant rejection drug
Reuters
Tuesday, August 28, 2012 - 11:28am
tags:
Genzyme, kidney transplant, rejections, Sanofi, recalls, Thymoglobulin
ImmunoGen Rises On Partner Roche’s Results
Bloomberg
Tuesday, August 28, 2012 - 11:22am
tags:
breast cancer, Roche, Immunogen, T-DM1
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tuesday, August 28, 2012 - 11:07am
tags:
Cell Therapeutics, Momenta, Onyx, Amag Pharmaceuticals, Biomarin, M&A, Celgene, Seattle Genetics, Galena Biopharma, ImmunoCellular, Amgen, Celldex, Dendreon, GSK, Vical, Oncothyreon, Biogen Idec, Merck KGaA, Bristol-Myers Squibb, Allos, Spectrum Pharmaceuticals, AstraZeneca
Gilead pricing for Stribild makes sense, says Deutsche Bank
The Fly on the Wall
Tuesday, August 28, 2012 - 11:02am
tags:
HIV, Gilead, Stribild, pricing
Gilead’s 4-In-1 Stribild HIV Pill Wins U.S. FDA Approval
Bloomberg
Tuesday, August 28, 2012 - 10:56am
tags:
Gilead, FDA, HIV, Quad, Stribild
A New CEO for AstraZeneca
Motley Fool
Tuesday, August 28, 2012 - 10:55am
tags:
Pharma CEOs, AstraZeneca, Pascal Soriot, Roche
Merck's Blockbuster Drug Januvia And Its Competitors
Seeking Alpha
Tuesday, August 28, 2012 - 10:54am
tags:
Merck, Januvia, diabetes, AstraZeneca, Bristol-Myers Squibb, JNJ, Novartis, Sanofi, Takeda
Bristol-Myers Squibb: Amylin Acquisition Will Pay Off In The Long-Term
Seeking Alpha
Monday, August 27, 2012 - 5:27pm
tags:
Amylin, M&A, Bristol-Myers Squibb, Merck, Eli Lilly, AstraZeneca, diabetes
Merck will seek approval of 2 heart drugs in 2013
Yahoo/AP
Monday, August 27, 2012 - 5:26pm
tags:
Merck, Vorapaxar, bloodthinners, Tredaptive
Merck's Next-Gen Sleep Disorder Drug - A Blockbuster?
Seeking Alpha
Monday, August 27, 2012 - 5:25pm
tags:
Merck, insomnia, Eli Lilly, Somaxon, Sanofi, suvorexant
No more bids for Par Pharma, so $1.9B deal with TPG stands
Fierce Pharma
Monday, August 27, 2012 - 12:36pm
tags:
M&A, Par Pharmaceutical, TPG
AstraZeneca Pays $26M To Settle Seroquel Suit
Pharmalot
Monday, August 27, 2012 - 12:33pm
tags:
Seroquel, AstraZeneca, settlements
Neuralstem Completes Phase I ALS Stem Cell Trial
Yahoo
Monday, August 27, 2012 - 12:31pm
tags:
ALS, Neuralstem, NSI-566
Can Anything Stop Regeneron Pharmaceuticals?
Motley Fool
Monday, August 27, 2012 - 12:29pm
tags:
Regeneron

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.